J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall ...

As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.

Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...

Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

Investment in 2025 has reached $9.9 billion, exceeding the $8.4 billion that was raised through the third quarter last year, ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as ...

Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.